An epidemiological assessment of health status among a cohort of tuberculosis survivors: prospective research in a western Indian city
Abstract
Long-term follow-up of tuberculosis (TB) is important to monitor treatment outcomes, prevent relapse, and improve patient care. The objectives of the current study are the following: i) to assess various epidemiological parameters among TB survivors, like mortality and morbidity, with emphasis on recurrence status during pre-defined long-term follow-up; ii) to assess factors responsible for the recurrence of TB among study participants. A prospective observational study was conducted among cured cases of pulmonary TB registered at the TB unit of Ahmedabad City, India. As per the calculated sample size, 180 study participants were recruited by systematic random sampling from a list of cured TB cases from July to September 2021. Follow-ups of participants were conducted at 6, 12, 18, and 24 months post-recruitment. The status of cured cases was assessed by a pre-validated questionnaire. Factors significantly associated with the likelihood of recurrent TB were analyzed using logistic regression. Of the total 180 cured TB cases, 22 (12.2%) developed recurrent TB, and 12 (6.6%) deaths were recorded during the entire follow-up duration of 2 years. Among the cases assessed, 106 (71.6%) were found to be asymptomatic in the context of TB at 2 years post-treatment completion. Around 17 (77.2%) recurrent cases were diagnosed within a year of treatment completion. Factors significantly associated with recurrence were age (p=0.01), body mass index (p=0.02), and socio-economic status (p=0.03) of the study population. Overall recurrence assessed during 2 years of post-treatment follow-up among the cohort of TB survivors was 12.2%. As per the study findings, socio-demographic and nutritional factors play a significant role in the development of recurrent TB, highlighting the importance of targeted interventions.
Ethics Approval
This research has been ethically approved by Institutional ethics committee (No. GCSMC/EC/Research Project/ APPROVE/2021/319 Dated 3 August 2021).
References
- WHO. Tuberculosis. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed on: 10/04/2024.
- Millet JP, Shaw E, Orcau A, et al. Tuberculosis recurrence after completion treatment in a european city: reinfection or relapse? PLoS One 2013;8:e64898. DOI: https://doi.org/10.1371/journal.pone.0064898
- Sadacharam K, Gopi PG, Chandrasekaran V, et al. Status of smear-positive TB patients at 2-3 years after initiation of treatment under a DOTS programme. Indian J Tuberc 2007;54:199-203.
- Azhar GS. DOTS for TB relapse in India: a systematic review. Lung India 2012;29:147-53. DOI: https://doi.org/10.4103/0970-2113.95320
- Dave P, Rade K, Modi B, et al. assessment of long-term outcome among new smear positive pulmonary TB patients treated with intermittent regimen under RNTCP – a retrospective cohort study. Natl J Community Med 2013;4:189-94.
- National Tuberculosis Elimination Pogramme. Long term post-treatment follow up of TB patients. Available from: https://ntep.in/node/611/CP-long-term-post-treatment-follow-tb-patients. Accessed on: 10/04/2024.
- Ahmedabad District, Government of Gujarat. History. Available from: https://ahmedabad.nic.in/history/. Accessed on: 10/04/2024.
- Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench 2013;6:14-7.
- Lambert M, Hasker E, Deun A, et al. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003;3:282-7. DOI: https://doi.org/10.1016/S1473-3099(03)00607-8
- Giridharan P, Selvaraju S, Rao R, et al. Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey. PLoS One 2023;18:e0294254. DOI: https://doi.org/10.1371/journal.pone.0294254
- Anaam MS, Alrasheedy AA. Recurrence rate of pulmonary tuberculosis in patients treated with the standard 6-month regimen: findings and implications from a prospective observational multicenter study. Trop Med Infect Dis 2023;8:110. DOI: https://doi.org/10.3390/tropicalmed8020110
- Mathur N, Chatla C, Syed S, et al. Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India. Lung India 2019;36:519-24. DOI: https://doi.org/10.4103/lungindia.lungindia_143_19
- Agarwal AK, Aharwal D, Verma R, et al. Observation study among cured cases of pulmonary tuberculosis: a long-term study under the revised national tuberculosis control program. J Epidemiol Public Health 2023;8:223-32. DOI: https://doi.org/10.26911/jepublichealth.2023.08.02.07
- Thomas A, Gopi PG, Santha T, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005;9:556-61.
- Joseph MR, Thomas RA, Nair S, et al. Directly observed treatment short course for tuberculosis. What happens to them in the long term? Indian J Tuberc 2015;62:29-35. DOI: https://doi.org/10.1016/j.ijtb.2015.02.005
- Sharma R, Prajapati S, Patel P, et al. An outcome-based follow-up study of cured category I pulmonary tuberculosis adult cases from various tuberculosis units under revised national tuberculosis control program from a western Indian city. Indian J Community Med 2019;44:48-52. DOI: https://doi.org/10.4103/ijcm.IJCM_310_18
- Bobokhojaev OI. Long-term results of 10 years of observation of cured cases of pulmonary tuberculosis. J Pulmonol Respir Res 2022;6:007-011. DOI: https://doi.org/10.29328/journal.jprr.1001036
- Verma SK, Kant S, Kumar S, Prasad R. A five-year follow-up study of revised national tuberculosis control programme of India at Lucknow Indian J Chest Dis Allied Sci 2008;50:195-7.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.